Missak Haigentz

Papers

Total Citations

H-Index

About

Missak Haigentz is a leading oncologist whose research has significantly advanced the treatment of head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCCA). His most impactful work investigates the role of transoral robotic surgery (TORS) in reshaping therapeutic paradigms. In a highly cited 2015 study (66 citations), Haigentz and his team prospectively evaluated patients undergoing TORS and neck dissection, demonstrating how this minimally invasive approach can reduce the need for aggressive adjuvant therapies. This work has been instrumental in shifting clinical practice toward more precise, function-preserving surgical interventions. Beyond this, Haigentz’s broader contributions encompass the integration of novel surgical techniques with personalized treatment planning, aiming to improve both survival outcomes and quality of life for patients. His research has garnered substantial recognition within the oncology community, influencing guidelines and inspiring further investigation into robotic-assisted procedures. For students and researchers, Haigentz’s work exemplifies how translational research can directly impact patient care, offering a compelling model for combining surgical innovation with rigorous clinical investigation to address critical challenges in cancer treatment.